Osimertinib

3 registered clinical trials studyying Osimertinib — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Orlistat Overcoming Third-generation EGFR-TKI Resistance NCT06818955	Ping Peng	Phase 2
Unknown	Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC NCT05458726	Peking Union Medical College	Phase 2
Active Not Recruiting	Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases NCT07491211	Fudan University	—